Genomics is central to the diagnosis, risk stratification and prognosis, disease monitoring, and therapeutic decision-making in hematologic malignancies. Clinicians managing patients with hematologic malignancies are faced with making decisions about which tests to order and when, interpreting test results, and which therapies to select–including when to start, stop, adjust, or change. 

This program will provide clinicians treating hematologic malignancies with a foundational understanding of genomics, expert insights on the current applications/practical strategies of genetic testing, and real-world patient case examples to demonstrate how to apply new knowledge of genomics to the optimal management of patients.